GLTO Galecto
- 0.608
- -0.002-0.33%
Galecto News
Express News | Galecto Announces First Patient Dosed In Investigator-Initiated Phase 2 Trial Of GB1211 In Combination With Pembrolizumab
Express News | Galecto Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of Gb1211 in Combination With Pembrolizumab
12 Health Care Stocks Moving In Friday's After-Market Session
GainersQilian Intl Hldg Gr (NASDAQ:QLI) stock moved upwards by 50.4% to $1.14 during Friday's after-market session. The company's market cap stands at $40.7 million. Allarity Therapeutics (NASDAQ:ALLR
12 Health Care Stocks Moving In Monday's After-Market Session
GainersOpGen (NASDAQ:OPGN) shares moved upwards by 24.0% to $0.74 during Monday's after-market session. The market value of their outstanding shares is at $7.4 million. Galecto (NASDAQ:GLTO) shares in
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersMolina Healthcare (NYSE:MOH) stock moved upwards by 24.2% to $503.11 during Wednesday's after-market session. The company's market cap stands at $29.3 billion. Evoke Pharma (NASDAQ:EVOK) shares
Galecto, Inc. (GLTO) Upgraded to Strong Buy: What Does It Mean for the Stock?
Will Galecto (NASDAQ:GLTO) Spend Its Cash Wisely?
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersKaruna Therapeutics (NASDAQ:KRTX) stock moved upwards by 47.9% to $318.17 during Friday's pre-market session. The company's market cap stands at $12.0 billion. Senti Biosciences (NASDAQ:SNTI) s
Nike, AAR And 3 Stocks To Watch Heading Into Friday
With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: NIKE, Inc. (NYSE:NKE) posted better-than-expected earnings for its s
Express News | Galecto Shares Are Trading Higher After the Company Announced Topline Results From a Phase 2a Trial of GB2064 for the Treatment of Myelofibrosis
Galecto Stock Rallies 25% on Positive Data for Myelofibrosis Drug
Topline Results From MYLOX-1 Trial Demonstrate Reduction in Fibrosis of the Bone Marrow in Patients With Myelofibrosis
BOSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ:GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced positive topline
Oppenheimer Remains a Buy on Galecto (GLTO)
H.C. Wainwright Sticks to Their Hold Rating for Galecto (GLTO)
Galecto Presents Updated Clinical Data at ESMO Congress 2023 and Provides Update on Phase 1b/2a GALLANT-1 Trial
Partial response seen in three of five patients with advanced non-small cell lung cancer who received GB1211 100 mg plus atezolizumab for at least three weeksBOSTON, Oct. 23, 2023 (GLOBE NEWSWIRE) -
Analysts Offer Insights on Healthcare Companies: Galecto (GLTO), Encompass Health (EHC) and Caribou Biosciences (CRBU)
Galecto Cut to Neutral From Buy by HC Wainwright & Co.
Galecto Cut to Neutral From Buy by HC Wainwright & Co.
HC Wainwright & Co. Downgrades Galecto to Neutral
HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Galecto (NASDAQ:GLTO) from Buy to Neutral.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersGalecto (NASDAQ:GLTO) shares increased by 31.3% to $0.75 during Wednesday's pre-market session. The market value of their outstanding shares is at $20.3 million. MSP Recovery (NASDAQ:LIFW) shar
Costco Wholesale, Paychex And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Paychex, Inc. (NASDAQ:PAYX) to report quar
Analysis
Price Target
No Data
